Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04027946
Brief Title: LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

First Submitted : July 19, 2019
First Submitted that Met QC Criteria : July 19, 2019
First Posted : July 22, 2019

Last Update Submitted that Met QC Criteria : December 30, 2021
Last Update Posted : January 3, 2022